BridgeMD
New treatment option for Subacute Stroke
Official title Phase I Split-Belt Treadmill Dosing for Subacute Stroke
ClinicalTrials.gov ID: NCT07469163
What this study is testing
- What it's testing
- After experiencing a stroke, many individuals encounter difficulties with walking and balance, which can significantly impact their independence. Recent studies have indicated that split-belt treadmill (SBT) training is effective for improving gait metrics, including walking speed and step length asymmetry.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Ischemic or hemorrhagic stroke survivors
- First stroke
- Over 18 years old
- Between one week and three months post-stroke
- can understand task instructions.
You likely can't join if
- History of significant neurological diseases (e.g. Multiple Sclerosis, Parkinson's disease)
- Orthopedic issues in lower extremities (e.g. severe knee Osteoarthritis)
- Excessive pain preventing participants from participating in treadmill-based activities
- Cerebellar stroke
- Body weight more than 560 lbs (this exceeds the weight limit of the support harness)
The study team makes the final eligibility decision.
Where it's taking place
- Calgary, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Calgary, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.